Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6509
    +0.0009 (+0.14%)
     
  • OIL

    82.66
    -0.15 (-0.18%)
     
  • GOLD

    2,331.70
    -6.70 (-0.29%)
     
  • Bitcoin AUD

    98,674.97
    -3,855.08 (-3.76%)
     
  • CMC Crypto 200

    1,386.30
    -37.80 (-2.65%)
     
  • AUD/EUR

    0.6076
    +0.0006 (+0.09%)
     
  • AUD/NZD

    1.0950
    +0.0008 (+0.07%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,232.80
    +31.53 (+0.18%)
     
  • NIKKEI 225

    37,778.75
    -681.33 (-1.77%)
     

3 Stocks That Have Soared as the Market Sank: Are They Buys Now?

3 Stocks That Have Soared as the Market Sank: Are They Buys Now?

It's hard for any stock to deliver positive gains while the market is falling. Molecular Partners' (NASDAQ: MOLN) shares have skyrocketed more than 40% year to date. On Jan. 10, Molecular Partners and Novartis announced positive results from their Empathy phase 2 study of ensovibep in treating acute COVID-19 patients.